Skip to content

The study on the effects of propofol on cardiac function, inflammatory mediators and pharmacokinetics in obese patients

The study on the effects of propofol on cardiac function, inflammatory mediators and pharmacokinetics in obese patients

Status
Recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015753
Enrollment
Unknown
Registered
2018-04-18
Start date
2018-04-20
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

morbid obesity

Interventions

Obesity group I:given a single intravenous injection for propofol dosage of 2mg/kg according to total body weight(TBW)
Obesity group II:received a propofol dosage of 2mg/kg according to lean body weight(LBW).
normal group:given a single intravenous injection for propofol dosage of 2mg/kg according to total body weight(TBW)

Sponsors

Department of Anesthesiology,the First Affiliated Hospital,Jinan University ,Guangzhou
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 50 Years

Inclusion criteria

Inclusion criteria: (1) between 20-45 years of age; (2) obesity index BMI = 35-40kg/m2,Normal weight patient body mass index 18.5-24kg/m2; (3) estimate the operation time between 2-2.5H; (4) according to the American Society of anesthesiologists standard ASA grade level I-II; (5) the function of lung, liver and kidney is normal, no other diseases such as cardiovascular system; (6) Patient is not allergic to propofol.

Exclusion criteria

Exclusion criteria: (1) with history of smoking; (2) Age less than 15 or greater than 50 according to the American Society of anesthesiologists standard ASA grade level III or above. Neurological dysfunction.Patients taking psychotropic drugs recently; (3) In addition to simple obesity, people with hypertension and/or diabetes.

Design outcomes

Primary

MeasureTime frame
Bispectral Index;Inflammatory mediator;Hemodynamic index;Blood concentration;

Countries

China

Contacts

Public ContactXuemei Peng

the First Affiliated Hospital, Jinan University, Guangzhou

464463169@qq.com+86 18928869988

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026